Browse by Phase
Phase 2 / Phase 3 Clinical Trials
Phase 2/3 combined trials bridge efficacy assessment and large-scale comparison, enrolling larger cohorts while still gathering dose-response data.
Total Trials
104
Recruiting Now
104
Top Conditions in Phase 2 / Phase 3
NCT07163611 Phase 2, Phase 3
Recruiting
Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a ...
Condition
Membranous Nephropathy - PLA2R Induced
Enrollment
20 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen
NCT05605704 Phase 2, Phase 3
Recruiting
Olive Leaf Extracts in the Control of Diabet
Condition
Diabetes Mellitus, Type 2
Enrollment
500 pts
Location
Tunisia
Sponsor
University of Monastir
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Y...
Condition
Haematological Malignancy
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT07342205 Phase 2, Phase 3
Recruiting
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Thr...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
60 pts
Location
China
Sponsor
Shanghai University of Traditi
NCT04353375 Phase 2, Phase 3
Recruiting
HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
Condition
Advanced Intrahepatic Cholangiocarcinoma
Enrollment
235 pts
Location
China
Sponsor
Hutchmed
NCT07302919 Phase 2, Phase 3
Recruiting
Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone i...
Condition
Hepato Cellular Carcinoma (HCC)
Enrollment
152 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw
NCT06427707 Phase 2, Phase 3
Recruiting
The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infu...
Condition
Intraoperative Bleeding
Enrollment
90 pts
Location
Egypt
Sponsor
Ain Shams University
NCT05961202 Phase 2, Phase 3
Recruiting
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
Condition
Inflammatory Cardiomyopathy
Enrollment
200 pts
Location
China
Sponsor
Tongji Hospital
NCT06536751 Phase 2, Phase 3
Recruiting
Therapeutic Photobiomodulation and Tretament of Spasticity
Condition
Muscle Spasticity
Enrollment
28 pts
Location
Brazil
Sponsor
University of Nove de Julho
NCT06529029 Phase 2, Phase 3
Recruiting
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral...
Condition
Suicidal Ideation
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
NCT06822049 Phase 2, Phase 3
Recruiting
Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1...
Condition
Remote vs. In-Person
Enrollment
200 pts
Location
United States
Sponsor
State University of New York a
NCT03937661 Phase 2, Phase 3
Recruiting
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
Condition
Ovary; Anomaly
Enrollment
100 pts
Location
Greece
Sponsor
Genesis Athens Clinic
NCT04715958 Phase 2, Phase 3
Recruiting
Prediction of Neoadjuvant Chemotherapy Response Using Contrast-Enhanced Ultrasou...
Condition
Anatomic Stage III Breast Cancer AJCC v8
Enrollment
200 pts
Location
United States
Sponsor
Kibo Nam
NCT06924762 Phase 2, Phase 3
Recruiting
Interleukin-2 for Refractory Chronic Spontaneous Urticaria
Condition
Chronic Spontaneous Uriticaria
Enrollment
124 pts
Location
China
Sponsor
Second Xiangya Hospital of Cen
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT05713851 Phase 2, Phase 3
Recruiting
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) ...
Condition
AKI - Acute Kidney Injury
Enrollment
100 pts
Location
Mexico
Sponsor
Instituto Nacional de Ciencias
NCT05004129 Phase 2, Phase 3
Recruiting
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dyst...
Condition
Congenital Myotonic Dystrophy
Enrollment
76 pts
Location
United States, Australia, Canada
Sponsor
AMO Pharma Limited
NCT06125327 Phase 2, Phase 3
Recruiting
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fi...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
210 pts
Location
China
Sponsor
Guangzhou JOYO Pharma Co., Ltd
NCT06532656 Phase 2, Phase 3
Recruiting
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
Condition
HIV-1-infection
Enrollment
75 pts
Location
United States, Argentina, Italy
Sponsor
Gilead Sciences
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endo...
Condition
Endometrial Cancer
Enrollment
268 pts
Location
United States, Austria, Canada
Sponsor
Kartos Therapeutics, Inc.
NCT06065657 Phase 2, Phase 3
Recruiting
Effect of Nutritional Ketosis on Alcohol Metabolism
Condition
Ketoses, Metabolic
Enrollment
20 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06563245 Phase 2, Phase 3
Recruiting
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Asse...
Condition
Classical Hodgkin Lymphoma
Enrollment
96 pts
Location
China
Sponsor
Children's Cancer Group, China
NCT07426094 Phase 2, Phase 3
Recruiting
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation i...
Condition
Prostate Cancer
Enrollment
1,600 pts
Location
Poland
Sponsor
Affidea Nu-med Center of Oncol
NCT07221370 Phase 2, Phase 3
Recruiting
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infec...
Condition
Clostridium Difficile Infection
Enrollment
176 pts
Location
United States
Sponsor
Riverside University Health Sy
NCT04932577 Phase 2, Phase 3
Recruiting
Faecal Microbiota Transplantation for Liver Cirrhosis
Condition
Liver Cirrhosis
Enrollment
220 pts
Location
Denmark
Sponsor
University of Aarhus
Page 1 of 5 — 104 trials total